# Pilot Study of Haloperidol to Treat Critical Illness Delirium

> **NCT00429676** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 20 (estimated)

## Conditions studied

- Delirium
- Critical Illness

## Interventions

- **DRUG:** Haloperidol

## Key facts

- **NCT ID:** NCT00429676
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00429676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00429676, "Pilot Study of Haloperidol to Treat Critical Illness Delirium". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00429676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*